Hybrid Magnetic Nanoparticles for Targeted Delivery
| hal.structure.identifier | Institut de Chimie de la Matière Condensée de Bordeaux [ICMCB] | |
| dc.contributor.author | EPHERRE, Romain | |
| hal.structure.identifier | Institut de Chimie de la Matière Condensée de Bordeaux [ICMCB] | |
| dc.contributor.author | GOGLIO, Graziella | |
| hal.structure.identifier | Institut de Chimie de la Matière Condensée de Bordeaux [ICMCB] | |
| dc.contributor.author | MORNET, Stéphane | |
| hal.structure.identifier | Institut de Chimie de la Matière Condensée de Bordeaux [ICMCB] | |
| dc.contributor.author | DUGUET, Etienne | |
| dc.contributor.editor | Paul Ducheyne | |
| dc.date.accessioned | 2023-11-20T17:27:53Z | |
| dc.date.available | 2023-11-20T17:27:53Z | |
| dc.date.issued | 2011 | |
| dc.identifier.isbn | 978-0-08-055302-3 | |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/185923 | |
| dc.description.abstractEn | Magnetic nanoparticles (MNPs) have attracted attention in modern medicine and pharmacology because of their potential usefulness as contrast agents for magnetic resonance imaging (MRI), as colloidal mediators for cancer magnetic hyperthermia or as active constituents of drug delivery platforms. This review examines these in vivo applications through an understanding of the involved problems and the current and future possibilities for resolving them. A special emphasis is made on MNP requirements from a physical viewpoint (e.g., relaxivity for MRI, specific absorption rate for hyperthermia, magnetic guidance), the factors affecting their biodistribution after intravenous injection (e.g., size, colloidal stability, surface hydrophobic/hydrophilic balance) and the solutions envisaged for enhancing their half-life in the blood compartment and targeting tumor cells. | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.publisher.location | Amsterdam | |
| dc.source.title | Comprehensive Biomaterials | |
| dc.subject.en | Biofunctionalization | |
| dc.subject.en | Biomedical applications | |
| dc.subject.en | Cancer | |
| dc.subject.en | Contrast agent | |
| dc.subject.en | Drug delivery | |
| dc.subject.en | Hyperthermia | |
| dc.subject.en | Magnetic fluids | |
| dc.subject.en | Magnetic guidance | |
| dc.subject.en | Magnetic nanoparticles | |
| dc.subject.en | Magnetic resonance imaging | |
| dc.subject.en | Stealthiness | |
| dc.subject.en | Synthesis | |
| dc.subject.en | Targeting | |
| dc.title.en | Hybrid Magnetic Nanoparticles for Targeted Delivery | |
| dc.type | Chapitre d'ouvrage | |
| dc.identifier.doi | 10.1016/B978-0-08-055294-1.00145-8 | |
| dc.subject.hal | Chimie/Matériaux | |
| bordeaux.page | 575-593 | |
| bordeaux.hal.laboratories | Institut de Chimie de la Matière Condensée de Bordeaux (ICMCB) - UMR 5026 | * |
| bordeaux.issue | 4 | |
| bordeaux.institution | Université de Bordeaux | |
| bordeaux.institution | Bordeaux INP | |
| bordeaux.institution | CNRS | |
| bordeaux.title.proceeding | Comprehensive Biomaterials | |
| hal.identifier | hal-04161666 | |
| hal.version | 1 | |
| hal.popular | non | |
| hal.audience | Internationale | |
| hal.origin.link | https://hal.archives-ouvertes.fr//hal-04161666v1 | |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.btitle=Comprehensive%20Biomaterials&rft.date=2011&rft.issue=4&rft.spage=575-593&rft.epage=575-593&rft.au=EPHERRE,%20Romain&GOGLIO,%20Graziella&MORNET,%20St%C3%A9phane&DUGUET,%20Etienne&rft.isbn=978-0-08-055302-3&rft.genre=unknown |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||